<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8044C2F3-70A8-44B3-A919-3A5ADEFD2311"><gtr:id>8044C2F3-70A8-44B3-A919-3A5ADEFD2311</gtr:id><gtr:name>Francis Crick Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19D01239-9063-4914-9D02-3D494BE14627"><gtr:id>19D01239-9063-4914-9D02-3D494BE14627</gtr:id><gtr:name>Royal Brompton &amp; Harefield NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/54DD1434-8E55-44C2-B306-EF88E4994299"><gtr:id>54DD1434-8E55-44C2-B306-EF88E4994299</gtr:id><gtr:name>Institut de Recherche en Sciences de la Sante</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8044C2F3-70A8-44B3-A919-3A5ADEFD2311"><gtr:id>8044C2F3-70A8-44B3-A919-3A5ADEFD2311</gtr:id><gtr:name>Francis Crick Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19D01239-9063-4914-9D02-3D494BE14627"><gtr:id>19D01239-9063-4914-9D02-3D494BE14627</gtr:id><gtr:name>Royal Brompton &amp; Harefield NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/54DD1434-8E55-44C2-B306-EF88E4994299"><gtr:id>54DD1434-8E55-44C2-B306-EF88E4994299</gtr:id><gtr:name>Institut de Recherche en Sciences de la Sante</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F010D808-6719-4C87-A924-2407D57C4F85"><gtr:id>F010D808-6719-4C87-A924-2407D57C4F85</gtr:id><gtr:firstName>Tony</gtr:firstName><gtr:surname>Cass</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5EA52880-1FD7-4A34-8630-0D96E0969CDF"><gtr:id>5EA52880-1FD7-4A34-8630-0D96E0969CDF</gtr:id><gtr:firstName>Stanley</gtr:firstName><gtr:surname>Kaye</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ED5EE42D-D408-4298-A273-BF125A5134C3"><gtr:id>ED5EE42D-D408-4298-A273-BF125A5134C3</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:surname>Coombes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8BCD7228-A8CE-4BEA-9B7E-3B061A3E753B"><gtr:id>8BCD7228-A8CE-4BEA-9B7E-3B061A3E753B</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Bloom</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B72318DE-EE7B-49DD-9D94-33D561409C14"><gtr:id>B72318DE-EE7B-49DD-9D94-33D561409C14</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Westwick</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E279948A-47AD-4FED-A1A1-EA5DFB86FDBB"><gtr:id>E279948A-47AD-4FED-A1A1-EA5DFB86FDBB</gtr:id><gtr:firstName>Sivaramesh</gtr:firstName><gtr:surname>Wigneshweraraj</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/96742227-7057-4683-AE49-6A893252696C"><gtr:id>96742227-7057-4683-AE49-6A893252696C</gtr:id><gtr:firstName>Molly</gtr:firstName><gtr:surname>Stevens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A8845E15-847D-4422-B52F-997B979B5B1C"><gtr:id>A8845E15-847D-4422-B52F-997B979B5B1C</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Bull</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B7B31661-D051-4ECB-A18E-B566A5BF4880"><gtr:id>B7B31661-D051-4ECB-A18E-B566A5BF4880</gtr:id><gtr:firstName>Lynne</gtr:firstName><gtr:surname>Murray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9AE6266B-C9DB-434C-986F-2DA25F69FC7F"><gtr:id>9AE6266B-C9DB-434C-986F-2DA25F69FC7F</gtr:id><gtr:firstName>Roberto</gtr:firstName><gtr:surname>Solari</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2D017551-27A1-4A44-9411-71B10309F61F"><gtr:id>2D017551-27A1-4A44-9411-71B10309F61F</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:otherNames>N</gtr:otherNames><gtr:surname>Weber</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A901E55A-AEDC-4CFE-A020-D17C51705D56"><gtr:id>A901E55A-AEDC-4CFE-A020-D17C51705D56</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Klug</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5DC00F54-1E33-4925-A70B-C5033939C039"><gtr:id>5DC00F54-1E33-4925-A70B-C5033939C039</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Moore</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0CA672F6-C27E-46EA-B135-4892258A585B"><gtr:id>0CA672F6-C27E-46EA-B135-4892258A585B</gtr:id><gtr:firstName>Raymond</gtr:firstName><gtr:otherNames>George</gtr:otherNames><gtr:surname>Hill</gtr:surname><gtr:orcidId>0000-0003-4070-3029</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15028"><gtr:id>39102F18-DDD9-49DF-936C-23F519D92926</gtr:id><gtr:title>Imperial Confidence in Concept: ICiC</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15028</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The Confidence in Concept scheme is a key part of MRC?s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach ?? before seeking more substantive funding.&amp;nbsp; It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>900000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Francis Crick Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wigneshweraraj - ICiC4 - Dr Luiz de Carvahlo, Crick Institute</gtr:description><gtr:id>6557D4F3-4118-497E-BAEA-7027DD3F6AA1</gtr:id><gtr:impact>We have obtained substantial preliminary data.</gtr:impact><gtr:outcomeId>58ca6f3a1c4896.38026011-1</gtr:outcomeId><gtr:partnerContribution>Provided metablome data.</gtr:partnerContribution><gtr:piContribution>We conceptualised the research idea.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Clinical Sciences</gtr:department><gtr:description>Development of graphene based biosensor for exosome analysis</gtr:description><gtr:id>CA95AA08-C52C-4C30-8B19-C3BC7EF3F881</gtr:id><gtr:impact>Multidisciplinary: Involving the field of biotechnology (microfluidic chip), physics (separation of particules using acoustic waves) and materials (use of graphene-based detection of exosomes)</gtr:impact><gtr:outcomeId>58ca69cb0986b7.83729807-1</gtr:outcomeId><gtr:partnerContribution>Graphene sensor fabrication
Electronic equipment to analyse sensor output
Surface analysis (XPS)</gtr:partnerContribution><gtr:piContribution>Providing biologicals (antibodies, exosomes) to be tested with the biosensor. 
Sample preparation and electron microscopy imaging of sensors. 
Microfluidic devices to integrate with sensor.Prototyping to increase device usability</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Brompton &amp; Harefield NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Griesenbach - ICiC4 - Dr Cliff Morgan</gtr:description><gtr:id>5424E573-4C40-493A-9739-BE4464567011</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c28e3fb338c6.12699951-1</gtr:outcomeId><gtr:partnerContribution>Disease expert</gtr:partnerContribution><gtr:piContribution>Expertise in pulmonary gene transfer and vector design.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institut de Recherche en Sciences de la Sante</gtr:collaboratingOrganisation><gtr:country>Burkina Faso</gtr:country><gtr:description>Blagborough - ICiC4 - Institut de Recherche en Sciences de la Sant&amp;eacute;, Burkina Faso</gtr:description><gtr:id>9A270E05-7CE6-40CB-86E3-1AA859C15767</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c829c28ba977.99172593-1</gtr:outcomeId><gtr:partnerContribution>Assessment of transmission-blocking capabilities of a Novel Whole-Parasite Anti-Malarial vaccine in the field by direct-membrane feeding assay (DMFA) on P. falciparum.</gtr:partnerContribution><gtr:piContribution>Design of and generation of materials to assess a Novel Whole-Parasite Anti-Malarial vaccine in the field.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Porter - ICiC4 - CRUK centre collaboration</gtr:description><gtr:id>5F044F76-8DC0-494E-AAB7-A6EF1EA5A45F</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58bd960121d179.09939854-1</gtr:outcomeId><gtr:partnerContribution>They organise the meetings and provide funding through the centre.</gtr:partnerContribution><gtr:piContribution>Alexandra Porter is a member of the CRUK centre. As such she is invited to events and to apply to funding calls from the centre, including studentships, fellowships pump prime funding. She attends meetings held by the CRUK centre at which she participates in brain storming sessions to come up with new research directions.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Wigneshweraraj - ICiC4 - Prof Boris Macek, University of Tubingen</gtr:description><gtr:id>11B6E3A4-67FA-48EB-A6F8-0FC91E60BBD5</gtr:id><gtr:impact>We have obtained substantial preliminary data.</gtr:impact><gtr:outcomeId>58ca71e21e2300.67302008-1</gtr:outcomeId><gtr:partnerContribution>Provided proteomics data.</gtr:partnerContribution><gtr:piContribution>We conceptualised the research idea.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Isalan - ICiC4 - Public Library of Science</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>128C8942-938D-425E-8EE7-44CAF1C798D7</gtr:id><gtr:impact>Online interview with PloS (Public Library of Science) which mentions this research on Huntington's disease.</gtr:impact><gtr:outcomeId>58c29f28292760.42589796</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://blogs.plos.org/everyone/2017/02/09/interview-with-plos-one-academic-editor-mark-isalan/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imperial festival 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A3162B9B-ACF5-45BB-81BA-CAB72187838C</gtr:id><gtr:impact>Imperial Festival is the College's flagship annual science outreach event celebrating the best science, engineering and creativity from Imperial. With hundreds of attractions, demonstrations, interactive exhibits, talks, tours, workshops and performances put on by more than 500 exhibitors from the College's academic and student community, the 2016 Imperial Festival attracted more than 15,000 visitors to the College. The CMBL group presented some of the cutting edge bioengineering research on the topic acoustic-based microfluidic devices for early cancer diagnostics and how simple blood tests will soon replace invasive tissue biopsies for early-stage detection of certain aggressive cancers, such as pancreatic cancer. The CMBL exhibition at the Festival was a tremendous success attracting well over 600 visitors over the weekend, from the very young to the old, children, families, science enthusiasts, academics and even investors and funding bodies. The feedback we received after the event has been overwhelmingly positive.</gtr:impact><gtr:outcomeId>58ca6cb5302752.25950076</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kedgley - ICiC4 - Women@Imperial Week</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2F9FE868-8621-4A56-91E7-B527B0773D97</gtr:id><gtr:impact>30 students and 2 teachers attended as part of the 2017 Demo lecture programme for schools, which has the aim of getting girls interested in Physics and Engineering. There were many questions from the students, including requests for further information about the programme, internships and careers in the field.</gtr:impact><gtr:outcomeId>58c2da0e48ac18.97113914</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kedgley - ICiC4 - Imperial College Human Factors Interest Group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1D5504D3-427A-4B23-9243-13AD5BD403FF</gtr:id><gtr:impact>Seminar presentation by Angela Kedgley, Imperial College Human Factors Interest Group (Nov 2016).

To link with other researchers and students in human factors to discuss key questions regarding how design affects patient concordance, monitoring, and compliance.</gtr:impact><gtr:outcomeId>58c2dc4e2593b8.67065654</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Larrouy-Maumus - ICiC4 - Imperial Festival/Super Bug Zone</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D01CE5F3-00E5-456B-BBB0-F141CEF52E81</gtr:id><gtr:impact>As part of the CMBI's outreach activities, we helped organising a few stands in the Superbug zone of the Imperial open to general public for awareness on AMR.</gtr:impact><gtr:outcomeId>58c2e7b3b8dba1.99177383</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Isalan - ICiC4 - Press release &amp; general web blogs interest</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DC27904B-FFF5-4EBD-A83E-959CC8C784B1</gtr:id><gtr:impact>After our press release our work has been picked up by many news agencies and has resulted in ongoing contacts with pharma and venture capitalists to find a route to translation.</gtr:impact><gtr:outcomeId>58c2a2c739a520.08142183</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_9-9-2016-13-13-26</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Solari - ICiC4 - Research Seminar at AstraZeneca in Mollndal, Sweden</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BFCCA426-7251-43F3-BCB9-5EECCEB855B5</gtr:id><gtr:impact>Roberto Solari gave a research seminar describing work conducted in his lab to the respiratory research groups at AstraZeneca in Sweden.</gtr:impact><gtr:outcomeId>58c0443a6d05f3.11493319</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mylonas - ICiC4 -  B.E.S.T. Innovation Symposium (IRCAD, IhU, France)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4B793EE7-44D1-4C31-96A0-4C2CF6D8960D</gtr:id><gtr:impact>Presentation of our concept at the B.E.S.T. Innovation Symposium, IRCAD, IhU in Strasburg, France (Aug 2016). Industry and postgraduate students attended from around the world. Interesting discussions followed, including valuable input from the industry perspective. The novelty of the approach was acknowledged.</gtr:impact><gtr:outcomeId>58c93f20d274c1.73802053</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.best-innovation.eu/best-innovation-symposium-2016/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tate - ICiC2 &amp; ICiC4 - CRUK lab tours, Imperial Festival 2016</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7DBDA761-F079-49FD-BD5A-0443B11DBFFD</gtr:id><gtr:impact>This event made us appreciate the importance of public engagement and we had positive feedback from attendees.</gtr:impact><gtr:outcomeId>58ca853f327511.48027348</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.imperial.ac.uk/festival/about/festival-2016/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Isalan - ICiC4 - Research *eu magazine interview</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DB4A68E7-00B3-47AF-95C1-F6E50C6B3CBA</gtr:id><gtr:impact>They interviewed Mark Isalan regarding the paper: Agust&amp;iacute;n-Pav&amp;oacute;n C, Mielcarek M, Garriga-Canut M &amp;amp; Isalan M. Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice. Molecular Neurodegeneration 11(1):64 (Sep. 2016). This resulted in a print/online magazine article.</gtr:impact><gtr:outcomeId>58c2981de1a314.22683746</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://cordis.europa.eu/news/rcn/126205_en.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Isalan - ICiC4 - La Vanguardia</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A5742997-ACA9-4B21-A6FF-B435C5AAD5DD</gtr:id><gtr:impact>Spanish newspaper coverage (print/online) of the paper:

Agust&amp;iacute;n-Pav&amp;oacute;n C, Mielcarek M, Garriga-Canut M &amp;amp; Isalan M. Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice. Molecular Neurodegeneration 11(1):64 (Sep. 2016).</gtr:impact><gtr:outcomeId>58c29d1cb9dc50.73125349</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.lavanguardia.com/vida/20160920/41451928214/una-inyeccion-reduce-enfermedad-de-huntington-en-ratones-durante-varios-meses.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Isalan - ICiC4 - Huffington Post</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>72EE12F1-5C25-4FBA-B8F6-4493D84116D3</gtr:id><gtr:impact>This was an online news article based on the paper:

Agust&amp;iacute;n-Pav&amp;oacute;n C, Mielcarek M, Garriga-Canut M &amp;amp; Isalan M. Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice. Molecular Neurodegeneration 11(1):64 (Sep. 2016).</gtr:impact><gtr:outcomeId>58c29b3467eed0.64216980</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.huffingtonpost.co.uk/entry/a-single-injection-of-a-new-treatment-has-halted-progress-of-huntingdons-disease-for-months_uk_57d69301e4b0d45ff8726d24</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Doctoral training centre in Neurotechnology</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>D7B114D3-AA66-4B24-9623-F72CF5A71AA2</gtr:id><gtr:outcomeId>58bd994ad0ffc2.15555472</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The discovery provides a novel method for predicting risk of cervical shortening, preterm labour (PTL), and for characterising a pregnant subject having a history of previous PTL, mid-trimester loss or cervical cone biopsy as being in need of surveillance and/or interventions to prevent PTL. This comprises of determining the expression level of one or more of the miRNA molecules identified in this discovery extracted from a biological sample obtained from said subject and comparing to a control value. The present discovery also provides biochips and kits for predicting risk of cervical shortening and/or PTL in a pregnant female subject, which consists of one or more probes specific for one or more of the miRNA molecules identified.</gtr:description><gtr:grantRef>MC_PC_15028</gtr:grantRef><gtr:id>1C2EDE2E-B5B1-4582-B9A4-D3EFC3AB7F89</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c81a5d008e98.16132397</gtr:outcomeId><gtr:patentId>WO2016/142688</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Method for predicting cervical shortening and preterm birth</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A surgical device comprising a deployable peripheral structure (inflatable or other) for insertion into a human or animal body, and one or more surgical tools disposed at least partially within the deployable peripheral structure and having a plurality of tendons connected thereto operable to manipulate the or each surgical tool.</gtr:description><gtr:grantRef>MC_PC_15028</gtr:grantRef><gtr:id>E81B8445-9368-45C7-B847-4ACE9BC9E320</gtr:id><gtr:impact>This is an enabling and potentially disrupting technology in the areas of minimally and ultra-minimally invasive surgery. Currently undergoing pre-clinical in vivo validation</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c959f73c1860.39936987</gtr:outcomeId><gtr:patentId>Application number PCT/GB2014/052744. Publication number WO2015036753</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Surgical device and methods</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The novel synthetic zinc finger proteins, delivered to the brain through the use of AAV viral vectors, have been designed to efficiently and selectively repress the mutant huntingtin gene. We have in vivo data in an acute mouse model of Huntington's Disease showing sustained repression after a single dose and restoration of motor coordination to levels comparable to those of healthy controls.</gtr:description><gtr:grantRef>MC_PC_15028</gtr:grantRef><gtr:id>EF4D038D-EFA3-4855-B205-63C1DAB4064D</gtr:id><gtr:impact>We are developing the technology to enter clinical trials.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>58c2b9f53cb345.21506221</gtr:outcomeId><gtr:patentId>GB 1519584.5 / PCT/GB2016/053454</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Novel Treatment for Huntington's Disease</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>N/A</gtr:description><gtr:grantRef>MC_PC_15028</gtr:grantRef><gtr:id>9EA63655-9D5A-4683-80CE-BEF13859A502</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>58ca8b16075157.65690058</gtr:outcomeId><gtr:patentId>GB Application No: 1511382.2  - WO2017001812A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Compounds and their use as inhibitors of N-myristoyl transferase</gtr:title><gtr:yearProtectionGranted>2017</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The novel synthetic zinc finger proteins, delivered to the brain through the use of AAV viral vectors, have been designed to efficiently and selectively repress the mutant huntingtin gene. We have in vivo data in an acute mouse model of Huntington's Disease showing sustained repression after a single dose and restoration of motor coordination to levels comparable to those of healthy controls.</gtr:description><gtr:grantRef>MC_PC_15028</gtr:grantRef><gtr:id>736B736A-9070-49B8-9A96-1660EB573FB3</gtr:id><gtr:impact>We are developing the technology to enter clinical trials.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>58c2a67c41f102.73765267</gtr:outcomeId><gtr:patentId>Application no.EP10187818.9 also published as WO/2012/049332. The patent is granted in US (US 9,096,682), Europe (2627668) and Australia (2011315378).</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Novel Treatment for Huntington's Disease</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>STEM for Britain 2017</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>4F7EB2D5-E0CE-4B8E-82F8-0D84463D5055</gtr:id><gtr:impact>Although there is no immediate change in any health policy, the research presented in the House of Commons by Antonios Chronopoulos entails the development of low-cost, portable microfluidic chips that leverage cutting-edge acoustic-based microfluidic technology and nanomaterials for non-invasive (blood-based) early detection of pancreatic cancer, thus obviating the need for invasive tissue biopsies.</gtr:impact><gtr:outcomeId>58ca6d38addc00.49507588</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We have developed a safe, cheap, and easily cultured transgenic rodent-malaria parasite which expresses a clinically-relevant human TBV antigen on its surface in native confirmation. Vaccination with these parasites produces an immune response against the native target with no cross-reactivity, and induces a potent transmission-blocking response. We have assessed the induced efficacy with a range of adjuvants/delivery systems/regimes using a variety of assays in both the lab and the field. Efficacy is favourable compared with other clinical TBVs under development. 

Our principle source of funding is an Imperial CiC award.</gtr:description><gtr:id>94341ED1-C686-4280-8AB3-356511586361</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c82dce8b5b84.22883119</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Blagborough - ICiC4 - A Whole-Parasite Anti-Malarial Transmission-Blocking Vaccine</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:yearDevCompleted>2017</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have chemically synthesised a number of novel protein kinase D inhibitors attempting to enhance cellular potency by targeting a Cys residue in the active site of the kinase.</gtr:description><gtr:id>640D18B5-56D8-428D-B7D7-91A205F430C4</gtr:id><gtr:impact>The new compounds are still being validated and tested in biological systems.</gtr:impact><gtr:outcomeId>58c0464d811e56.43789706</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Solari - ICiC4 - Novel Protein Kinase D Inhibitors</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A0BF3A0F-F64F-4B0D-8C44-9982DED27CEE</gtr:id><gtr:title>Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1687ce90cc1b1dce49e5e55e03d81325"><gtr:id>1687ce90cc1b1dce49e5e55e03d81325</gtr:id><gtr:otherNames>Sala KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9e9db18b7820.82609729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F010096-C667-4546-AAD9-79E92AB877E4</gtr:id><gtr:title>Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b175ed70e2f4e64434807995f1926859"><gtr:id>b175ed70e2f4e64434807995f1926859</gtr:id><gtr:otherNames>Agust?n-Pav?n C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>58c001d56dfb11.07967485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0E2E68C-C762-47C0-BA93-AD6385A8B73E</gtr:id><gtr:title>Exosomes as a platform for 'liquid biopsy' in pancreatic cancer</gtr:title><gtr:parentPublicationTitle>Convergent Science Physical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f45f98fbba605c58c16e6d69d8e5f583"><gtr:id>f45f98fbba605c58c16e6d69d8e5f583</gtr:id><gtr:otherNames>Chronopoulos A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58ca68ad5a9857.47829704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE93080D-C806-427B-BD71-9C70C0220878</gtr:id><gtr:title>Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3cbbb58c8ea208e52edad71680f8d28e"><gtr:id>3cbbb58c8ea208e52edad71680f8d28e</gtr:id><gtr:otherNames>Piotrowska I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5ab3e1054cf590.11959368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBECC536-E59E-4925-8967-6C1EECB225F8</gtr:id><gtr:title>Diagnosis of Bacterial Infection Using a 2-Transcript Host RNA Signature in Febrile Infants 60 Days or Younger</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a23e3642f1869e773a8efb409f7d608"><gtr:id>2a23e3642f1869e773a8efb409f7d608</gtr:id><gtr:otherNames>Kaforou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5ab27d0c5f2ed7.90660171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9753D59-6EF1-4CA9-81D3-52DFB0E0A477</gtr:id><gtr:title>Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis</gtr:title><gtr:parentPublicationTitle>The Lancet Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38e4f35e241e3ef7455c6c61e56bc3a1"><gtr:id>38e4f35e241e3ef7455c6c61e56bc3a1</gtr:id><gtr:otherNames>Arbyn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a9ea5391b85f8.49462865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAA263B8-3B43-4F20-9E95-9D3B6B500E26</gtr:id><gtr:title>Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff32cbfc4b139243f268e349dddc7ee6"><gtr:id>ff32cbfc4b139243f268e349dddc7ee6</gtr:id><gtr:otherNames>Gued?n A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>58bd9ef82498f5.31999903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>070BA853-7201-4A31-85AF-16E43FCF678C</gtr:id><gtr:title>A Scalable ISFET Sensing and Memory Array With Sensor Auto-Calibration for On-Chip Real-Time DNA Detection</gtr:title><gtr:parentPublicationTitle>IEEE Transactions on Biomedical Circuits and Systems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6a5b2b9ec75fef5c41c5768606124b"><gtr:id>0e6a5b2b9ec75fef5c41c5768606124b</gtr:id><gtr:otherNames>Moser N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5ab27f654e0181.46371223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CB42191-8F13-4651-A94D-A6F91B60AD37</gtr:id><gtr:title>Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb9c5d48c8dcf4897e3817b8dc39687d"><gtr:id>eb9c5d48c8dcf4897e3817b8dc39687d</gtr:id><gtr:otherNames>Mielcarek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn><gtr:outcomeId>5ab3e07b230996.11470287</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15028</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>